Eli Lilly’s $1.4 Billion Acquisition of POINT Biopharma

Kirkland & Ellis LLP is acting as legal counsel to Lilly, while Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal counsel to POINT…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here